Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients
-
Published:2022
Issue:
Volume:33
Page:100625
-
ISSN:2468-2942
-
Container-title:Cancer Treatment and Research Communications
-
language:en
-
Short-container-title:Cancer Treatment and Research Communications
Author:
Bairi Khalid ElORCID,
Trapani Dario,
Page Cécile Le,
Saad Anas,
Jarroudi Ouissam Al,
Afqir Said
Subject
Cancer Research,Oncology
Reference54 articles.
1. Validated biomarkers: the key to precision treatment in patients with breast cancer;Duffy;Breast,2016
2. Prediction of therapy response in ovarian cancer: where are we now?;El Bairi;Crit. Rev. Clin. Lab. Sci.,2017
3. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy;Havel;Nat. Rev. Cancer,2019
4. Le Page C., Amuzu S., Rahimi K., Gotlieb W., Ragoussis J., Tonin P.N. Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers [published online ahead of print, 2020 Aug 19]. Semin. Cancer Biol.. 2020;S1044-579X(20)30177-2. doi:10.1016/j.semcancer.2020.08.005.
5. Biomarker-guided therapy for colorectal cancer: strength in complexity;Sveen;Nat. Rev. Clin. Oncol.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献